Status:
COMPLETED
The Use of Midazolam as Adjuvant to Bupivacaine Intrathecal Anesthesia for Children Undergoing Lower Abdominal Surgeries.
Lead Sponsor:
Tanta University
Conditions:
Analgesia
Children, Only
Eligibility:
All Genders
3-12 years
Phase:
EARLY_PHASE1
Brief Summary
The study will be carried on children undergoing lower abdominal surgeries. Patients will be randomly categorized into two study groups. Group A will include patients who will receive bupivacaine intr...
Eligibility Criteria
Inclusion
- All children aged 3-12 years, assigned for lower abdominal and pelvic surgeries and will be ASA grade I after obtaining written fully informed parental consent.
Exclusion
- Patients with congenital anomalies especially of the spine, infections in the skin of the back, had coagulopathy, or allergy to the study drugs and those whose parents refused to give the consent .
Key Trial Info
Start Date :
January 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04718259
Start Date
January 18 2020
End Date
March 10 2021
Last Update
March 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alemeis hospital ksa
Jizan, Saudi Arabia, 00966